CCT301-38

· Shanghai PerHum Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCT301-38, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas [Phase 1]